AS

Astellas Venture Management

VC
Menlo Park, CAWebsite

Astellas Venture Management is a Seed, Pre-Seed venture capital firm based in Menlo Park, CA investing in Other, Healthcare, AI / ML. The firm typically writes $1.5M–$10.0M checks and has 16 portfolio companies in our records.

Check size
$1.5M–$10.0M
Portfolio
16 companies on record
Partners
5 listed
AUM
$68M
Stage
Seed, Pre-Seed
Sectors
Other, Healthcare, AI / ML
HQ
Menlo Park, CA

Last verified: 2026-05-04

How to approach: cold outreach ok
Stage

Seed, Pre-Seed

Check Size

$1.5M – $10.0M

AUM

$68M

Portfolio

16+ companies

Team

5 partners

Investor activity
Investments in last 12 months: 0

Investment Thesis

Astellas Venture Management invests in early-stage therapeutic innovation, focusing on biopharma and AI-based drug design.

How Astellas Venture Management invests

Astellas Venture Management is a vc firm based in Menlo Park, CA. The firm invests at the Seed, Pre-Seed stages, with a focus on Other, Healthcare, AI / ML.

Astellas Venture Management typically writes checks of $1.5M–$10.0M per investment, backed by approximately $68M in assets under management.

Astellas Venture Management has backed 16 companies in our records, including Atomwise, Vector BioPharma, DeepSeq.AI.

Partners & Team

SM

Shinichi Miyake, Ph.D., MBA

Investment Lead

Small Molecules
Cell Therapy
Gene Therapy
Modality-based Drug Discovery
WW

William Watt, Ph.D.

President

TH

Tadayoshi Hirata

Investment Lead

Early-stage partnering deals
Translational science
Clinical pharmacology
NS

Nagisa Sakurai, Ph.D., MBA

Investment Lead

Regenerative Medicine
Cardiovascular”, “Ophthalmology
Stem Cell Therapy
SK

Satoshi Konagai, MBA

Investment Lead

Oncology
Ophthalmology
Regenerative Medicine

Industry Focus

Invests In

Other
Healthcare
AI / ML

Portfolio Companies (16)

Other

AT

Atomwise

AI Drug Discovery
VE

Vector BioPharma

Biotech
DE

DeepSeq.AI

SE

Serna Bio

SO

Solu Therapeutics

Develops therapeutics targeting soluble targets in immunology and inflammation.

PH

PhoreMost

Oncology (immuno-oncology)·Series B - II

UK-based developer of small molecule neoantigen immuno-oncology therapies.

SO

Somite Therapeutics

Regenerative medicine (muscle)·Pre-Seed - II

Builds cellular therapies for muscle diseases using stem cell tech.

TU

Turn Biotechnologies

Health/Medical (regenerative)

Develops mRNA-based therapies for cellular rejuvenation in age-related diseases.

CO

CoMentis

Biotechnology (neuro)

Focuses on neurodegenerative disease therapies targeting protein misfolding.

AV

Avilar Therapeutics

Biotechnology (degradation)

Engineers protein degradation platforms for autoimmune and inflammatory diseases.

How to pitch Astellas Venture Management
  • Raising at Seed, Pre-Seed? You're squarely in their sweet spot.
  • Lead with your fit in Other, Healthcare, AI / ML — the sectors they actively back.
  • Size your ask to their typical $1.5M – $10.0M check.
  • cold outreach ok
  • Address your outreach to a specific partner, such as Shinichi Miyake, Ph.D., MBA, Investment Lead.
  • A warm introduction beats a cold email. Get matched and request an intro.

Featured In

Browse More Investors

Fundraising resources

Frequently Asked Questions

See if Astellas Venture Management is a match for your startup

Upload your pitch deck to see how well you match with Astellas Venture Management and 10,000+ other investors.

Is this your profile? Request a correction or removal